1. "Mark Robson"
Formats
  1. Journal Article (382)
  2. Meeting Abstract (259)
  3. Review (10)
  4. Book Section (7)
  5. Editorial (6)
  6. Guidelines (6)
  7. Miscellaneous (4)
  8. Correspondence (1)
  9. Research Letter (1)
Groups
  1. Breast Medicine Service (676)
  2. Department of Medicine (676)
  3. Population Sciences Research Program (676)
  4. Solid Tumor Oncology Division (676)
  5. Survivorship Research (676)
  6. GSK Faculty (376)

More Groups

People
  1. Mark Robson (676)
  2. Kenneth Offit (280)
  3. Zsofia Stadler (116)
  4. Larry Norton (89)
  5. Vijai Joseph (79)
  6. Diana Mandelker (74)

More People

Years
  1. 2025 (2)
  2. 2024 (32)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (46)
  6. 2020 (65)

More Years

Publications
  1. Journal of Clinical Oncology (163)
  2. Cancer Research (50)
  3. Breast Cancer Research and Treatment (33)
  4. JNCI: Journal of the National Cancer Institute (20)
  5. Annals of Oncology (18)
  6. Clinical Cancer Research (17)

More Publications

Publishers
  1. American Society of Clinical Oncology (185)
  2. American Association for Cancer Research (82)
  3. Springer (66)
  4. Nature Publishing Group (60)
  5. Elsevier Inc. (50)
  6. Oxford University Press (42)

More Publishers

Results (676)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hereditary breast cancer
    Book Section

    Robson, M. E.
    In Borgen, P. I.; Hill, A. D. K. (Eds.) Breast Diseases (2000)

    Fulltext@MSK | Save
  • Risk of ipsilateral recurrence (IBTR) and metachronous contralateral breast cancer (CBC) after breast conservation therapy (BCT) in women with germline BRCA1 or BRCA2 mutations
    Meeting Abstract

    Robson, M.; Roberge, D.; Satagopan, J.; Chappuis, P.; Boyd, J.; Offit, K.; Foulkes, W.
    Breast Cancer Research and Treatment (2000)

    Fulltext@MSK | Save
  • The presence of a germ-line BRCA mutation is an independent poor prognostic marker in breast cancer: A two-center historical cohort study
    Meeting Abstract

    Foulkes, W. D.; Satagopan, J. M.; Chappuis, P. O.; Wong, N.; Begin, L. R.; Boyd, J.; Offit, K.; Robson, M. E.
    American Journal of Human Genetics (2000)

    Fulltext@MSK | Save
  • Risk-reducing surgery outcomes among a series of BRCA heterozygotes
    Meeting Abstract

    Scheuer, L. M.; Robson, M.; Baum, R.; Capasso, M.; Duteau-Buck, C.; Hull, J.; Kelly, B.; McDermott, D.; Pierce, H.; Pinto, M.; more...
    American Journal of Human Genetics (2000)

    Fulltext@MSK | Save
  • De novo BRCA2 mutation in a patient with early-onset breast cancer
    Meeting Abstract

    Robson, M.; Scheuer, L.; Baum, R.; Hull, J.; McDermott, D.; Pierce, H.; Nafa, K.; Ellis, N.; Offit, K.
    American Journal of Human Genetics (2000)

    Fulltext@MSK | Save
  • Are BRCA1- and BRCA2-associated breast cancers different? Prognosis of BRCA1-associated breast cancer
    Journal Article

    Robson, M.
    Journal of Clinical Oncology (2000)

    Fulltext@MSK | Save
  • Screening for ovarian cancer: What we know, what we need to know
    Journal Article

    Hensley, M. L.; Castiel, M.; Robson, M. E.
    Oncology (Norwalk) (2000)

    Fulltext@MSK | Save
  • Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: A case-control study
    Journal Article

    Narod, S. A.; Brunet, J. S.; Ghadirian, P.; Robson, M.; Heimdal, K.; Neuhausen, S. L.; Stoppa-Lyonnet, D.; Lerman, C.; Pasini, B.; De Los Rios, P.; more...
    Lancet (2000)

    Fulltext@MSK | Save
  • Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes
    Journal Article

    Barakat, R. R.; Federici, M. G.; Saigo, P. E.; Robson, M. E.; Offit, K.; Boyd, J.
    Cancer (2000)

    Fulltext@MSK | Save
  • Absence of premalignant histologic, molecular, or cell biological alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes
    Meeting Abstract

    Barakat, R. R.; Federici, M. G.; Robson, M. E.; Offit, K.; Saigo, P. E.; Boyd, J.
    Gynecologic Oncology (1999)

    Fulltext@MSK | Save